7/15
08:30 am
allo
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
Low
Report
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
7/4
10:11 am
allo
Allogene Therapeutics: A High-Upside Bet On The Next Wave Of CAR-T Innovation [Seeking Alpha]
Low
Report
Allogene Therapeutics: A High-Upside Bet On The Next Wave Of CAR-T Innovation [Seeking Alpha]
6/28
01:36 am
allo
Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions [Yahoo! Finance]
Medium
Report
Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions [Yahoo! Finance]
6/12
12:51 pm
allo
Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report? [Yahoo! Finance]
6/7
02:15 pm
allo
Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio [Yahoo! Finance]
Low
Report
Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio [Yahoo! Finance]
5/28
08:03 pm
allo
Allogene Therapeutics Announces Planned CEO Succession [Yahoo! Finance]
Low
Report
Allogene Therapeutics Announces Planned CEO Succession [Yahoo! Finance]
5/28
05:02 pm
allo
Allogene Therapeutics Announces Planned CEO Succession
Low
Report
Allogene Therapeutics Announces Planned CEO Succession
5/26
01:31 pm
allo
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]
5/26
08:30 am
allo
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Medium
Report
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
5/13
10:16 pm
allo
Imugene valuation points to 129% upside as broker backs azer-cel strategy [Yahoo! Finance]
Medium
Report
Imugene valuation points to 129% upside as broker backs azer-cel strategy [Yahoo! Finance]
5/13
06:58 pm
allo
Allogene (ALLO) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Allogene (ALLO) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
5/13
04:02 pm
allo
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
Medium
Report
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
5/6
08:30 am
allo
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Medium
Report
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
5/1
05:39 am
allo
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock [Yahoo! Finance]
Low
Report
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock [Yahoo! Finance]
4/25
08:08 pm
allo
Allogene Therapeutics (ALLO): 10 Best Growth Stocks Under $10 to Invest In [Yahoo! Finance]
Low
Report
Allogene Therapeutics (ALLO): 10 Best Growth Stocks Under $10 to Invest In [Yahoo! Finance]
4/23
03:53 am
allo
H.C. Wainwright Maintains Buy Rating on Allogene Therapeutics (ALLO) [Yahoo! Finance]
Low
Report
H.C. Wainwright Maintains Buy Rating on Allogene Therapeutics (ALLO) [Yahoo! Finance]
4/21
08:30 am
allo
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
Medium
Report
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
4/20
08:30 am
allo
Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
Low
Report
Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026